Michael Cleary was recently appointed by Tullis Health Investors as its new Director of Investor Relations and Marketing. Tullis is a private equity and venture capital fund firm that has portfolio investments in pharmaceutical, medical technologies and services, biotechnology and healthcare companies.
Before joining Tullis, Cleary was the Managing Director for Equus Financial Consultants and prior to that, Managing Director for the private funds group at JP Morgan/Bear Sterans. Overall, he brings over three decades of investment and financial experience in the private equity sector at all levels.
In a statement, Cleary said, ""I am extremely excited to be joining Tullis Health Investors at this time, and contributing to its success and its expansion in the rapidly growing and dynamic healthcare sector worldwide. Healthcare spending is now 17% of US GDP and continues to grow. We anticipate significant changes in the US healthcare delivery model with many opportunities for profitable investing. Our population is aging, our technology is continuing to advance, and our needs for healthy solutions and for effective and cost efficient solutions have never been greater. I believe Tullis is well positioned, with its track record of successful investing in the healthcare industry, its team of experienced investment personnel and its broad connections and unique perspectives."
Join the Conversation